These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3567848)

  • 1. Prognostic factor in neuroblastoma.
    Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
    Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
    Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H; He X; Miao Q; Li L; Song J; Jiang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
    Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
    Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
    Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
    Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
    Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
    Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
    Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
    Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
    Hashimoto K; Gotoh Y; Tada K
    Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
    Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
    Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
    Simon T; Hero B; Hunneman DH; Berthold F
    Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma.
    Parodi S; Perfumo C; Garaventa A; Inga A; Mazzocco K; Defferrari R; Tonini GP; Fronza G; Haupt R
    Pediatr Blood Cancer; 2010 Aug; 55(2):267-72. PubMed ID: 20232446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin in stage IV neuroblastoma.
    Imashuku S; Yamanaka H; Morioka Y; Todo S
    Am J Pediatr Hematol Oncol; 1988; 10(1):39-41. PubMed ID: 3189716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First experience with prognostic factors in unselected neuroblastoma patients. The Austrian Neuroblastoma 87 Study.
    Ladenstein R; Urban C; Gadner H; Fink FM; Zoubek A; Emminger W; Grienberger H; Schmitt K; Ambros PF; Ambros IM
    Eur J Cancer; 1995; 31A(4):637-41. PubMed ID: 7576985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
    Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
    Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology.
    Silber JH; Evans AE; Fridman M
    Cancer Res; 1991 Mar; 51(5):1426-33. PubMed ID: 1997181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.